Research Division – JG Life Sciences
Pioneering Peptide Research for Regenerative Applications
JG Life Sciences is a Canadian-based R&D group focused on osteoanabolic compounds, growth hormone secretagogues, and signal modulation peptides.
Bone & Endocrine Division
Current Research Focus
Our current research explores the therapeutic potential of osteoanabolic and endocrine-modulating compounds. We are focused on:Teriparatide (PTH 1-34) — Investigating its role in bone regeneration and cortical thickening.MK-677 (Ibutamoren) — Analyzing GH/IGF-1 axis stimulation for musculoskeletal applications.Peptide analogs & vehicle interactions — Studying storage stability across pH and temperature ranges.Signal transduction modeling — Tracking cellular responses in bone-active pathways.All compounds are handled strictly for research use only. JG Life Sciences does not engage in clinical or human administration of any materials.
Non-Clinical Peptide Research
About JG Life Sciences
JG Life Sciences is an independent research group based in Edmonton, Alberta. Our work focuses on early-stage biochemical investigation into regenerative peptide compounds, signal transduction, and hormone analogs.We operate exclusively in non-clinical R&D, supporting internal studies and supplier-driven validation projects.
Contact & Research Inquiries
Let’s Connect
JG Life Sciences
10180 – 101 Street, Suite 3400
Edmonton, AB, T5J 3S4, Canada
📧 [email protected]
📞 +1 (780) 257-9790
All compounds are for research use only. Not for human or veterinary use.